Avicanna Announces US Patent and Trademark Office Issuance of New Patent
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 11 2025
0mins
Source: Newsfilter
Patent Issuance: Avicanna Inc. has received a patent (No. US 12,343,315 B2) from the USPTO for its topical cannabinoid compositions aimed at promoting clear skin, which may help treat conditions like acne and rosacea.
Company Overview: Avicanna is a biopharmaceutical company focused on developing and commercializing plant-derived cannabinoid products, with a diverse range of offerings including medical cannabis formulations and a pharmaceutical pipeline targeting unmet medical needs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
